## **Core Concept**
The nitroblue tetrazolium (NBT) test is a diagnostic tool used to assess the functioning of phagocytic cells, particularly neutrophils. It measures the ability of these cells to produce superoxides, which are crucial for killing ingested microorganisms. The test is specifically used to screen for chronic granulomatous disease (CGD), a primary immunodeficiency characterized by the inability of phagocytes to generate superoxides.

## **Why the Correct Answer is Right**
The correct answer, **Chronic Granulomatous Disease (CGD)**, is a genetic disorder that affects the production of reactive oxygen species (ROS) in phagocytic cells. This deficiency leads to recurrent life-threatening infections and the formation of granulomas. The NBT test detects the reduction of tetrazolium salts by superoxides produced in functioning phagocytes; in CGD, the lack of superoxide production results in a failure to reduce the dye, indicating a positive screening for the condition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is blank and cannot be evaluated.
- **Option B:** This option is blank and cannot be evaluated.
- **Option C:** This option is blank and cannot be evaluated.
- **Option D:** This option is blank and cannot be evaluated.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that CGD patients are particularly susceptible to infections with catalase-positive bacteria (like *Staphylococcus aureus*, *Escherichia coli*, and *Salmonella*) and fungi. The NBT test is a rapid and useful screening tool for diagnosing CGD, although confirmatory testing, such as flow cytometry for oxidative burst, is often required for a definitive diagnosis.

## **Correct Answer:** D. Chronic Granulomatous Disease.